Home | NRI | Business Associates | Knowledge Bank | Careers | Back Office | Contact Us
 

Get Quotes
Company Background
Board Of Directors
Balance Sheet
Profit & Loss Accounts
Quarterly Results
Key Financial Ratios
Share Price
Charts
 
 
Profit and Loss
Supriya Lifescience Ltd
    Industry   : Pharmaceuticals - Indian - Bulk Drugs & Formln  Chairman  : Satish Waman Wagh
    Home        : Indian Private  Book Value: 134.4133852
    BSE Code  : 543434  Market Cap: 5330.78
    NSE Code  : SUPRIYA  P / E              : 28.72 

Change Company :
(Rs in Cr.)
Profit and Loss
ParticularsMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Sales Turnover & Other Income 791.74657.57525.96596.10435.98
Excise Duty85.4476.5955.5358.4739.76
Total Income813.00627.26532.47599.13448.42
Raw Materials 232.44191.43187.32198.83140.57
Stock Adjustments 21.26-30.316.513.0312.44
Other Manufacturing Expenses 51.8135.6828.8718.4413.15
Power & Fuel Cost24.8021.3720.9514.079.24
Employee Cost 80.5267.6455.5849.0832.76
Selling and Administration Expenses 54.6538.1037.3233.8331.88
Miscellaneous Expenses 12.619.808.514.842.92
Less: Preoperative Expenditure Capitalised0.000.000.000.000.00
Profit before Interest, Depreciation & Tax270.73186.65138.39221.57178.15
Interest & Financial Charges 1.815.153.084.204.08
Profit before Depreciation & Tax268.92181.50135.31217.37174.07
Depreciation20.4415.8111.8210.126.76
Profit Before Tax248.48165.69123.49207.25167.31
Tax60.5246.5833.6355.4443.72
Profit After Tax187.96119.1189.86151.81123.59
Adjustment below Net Profit 0.000.000.000.000.00
P & L Balance brought forward600.45486.16401.13253.72134.08
Appropriations 6.444.834.834.393.96
P & L Bal. carried down781.97600.45486.16401.13253.72
Equity Dividend6.444.834.834.393.96
Preference Dividend0.000.000.000.000.00
Corporate Dividend Tax0.000.000.000.000.00
Equity Dividend (%)50.0040.0030.0030.0027.00
Earning Per Share (Rs.)23.3514.8011.1618.8616.89
Book Value123.84101.3186.9176.5036.70
Extraordinary Items -0.010.00-0.080.000.00
Top
BSE Disclaimer     |     Disclaimer     |     Privacy Statement     |     Terms of Use     |     Feedback     |    Sitemap     |    Downloads    |     Client Bank Details
Useful Links   | Risk Disclosure   | Rules and Regulations   |   Investor Charter / Complaints   |   Smart ODR   |   Scores   |   Attention Investors   | Audit Compliance Report   | RA – Annual Compliance Audit Report 2024-25   | UPI IDs for Payment

SEBI Saa₹thi Mobile App/SEBI Investor Website  

SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822
SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527
2006-07 © SSJ Finance & Securities Pvt. Ltd. All Rights Reserved Designed, Developed & Maintained By
C-MOTS InfoTech(ISO 9001:2015 & ISO/IEC 27001:2022 Certified)
Content powered by Capital Market Charts are powered by TradingView